Toxicology, ADME & Early Drug Development Plan

“Building an Integrated Safety Testing Strategy based on ADME and Toxicology”
Days
Hours
Minutes
Seconds

Toxicology, ADME & Early Drug Development Plan

Training features

Interactive discussions and Q&A sessions
Individual discussion & consultancy with the trainer

Case studies from the trainer's experience
Certificate of completion issued by the trainer
Comprehensive course documentation
Fully online

All sessions of this unique course also online

Live interaction

Live interaction options between the delegates and trainer

On any device

Available via mobile, tablet or laptop

meet the training leaders
Dr. Gerhard Hager
CEO
The NCD Company, Germany
Dr. Paolo Rossato
Associate Director, PK & QSP Unit, Pharmacology & Toxicology Department, Research
CSL Behring, Germany
Louise Mawer
GXP Auditor and Trainer
Mirabilitas Ltd, UK
training

Brochure

Reveal the full schedule of the training as well as key topics, course objectives, key takeaways, special features, and the trainer bio!

Toxicology, ADME and Early Drug Development Plan online live training Fleming Agenda cover
Toxicology, ADME and Early Drug Development Plan online live training Fleming Agenda cover
Toxicology, ADME and Early Drug Development Plan online live training Fleming Agenda cover
key training

Topics

Absorption, Distribution, Metabolism and Excretion (ADME) and Toxicology studies from Lead Optimization to application for First in Man (FIM) clinical trials

Synergies between ADME and Toxicology studies during early drug development

First human dose prediction

Quality standards during Early Drug Development

Early Drug Development Plan – strategy, design and critical milestones

Key regulatory documents & submission of ADME and Toxicology data

Benefits of attending

Registration

Training ticket

Delegate Fee
FROM
2396
Online Live Stream
FROM
1496

Contact us

DOWNLOAD THE BROCHURE AND REVEAL THE FULL PROGRAM DETAILS

Name
Job
Company
Bio
Name
Description